SHARON PATTON: Open Payments
NPI 1174887293 · COLUMBIA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,239 in 72 payments from 12 companies in 2025. Trend: 2023 $36 · 2024 $625 · 2025 $1,239
Food & beverage: $1,239
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 27 | $494 |
| Supernus Pharmaceuticals, Inc. | 14 | $198 |
| ABBVIE INC. | 9 | $146 |
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
| Lundbeck LLC | 5 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Corium, LLC | 3 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
Products named: HETLIOZ, FANAPT, Qelbree, REXULTI, VRAYLAR, TRINTELLIX, COBENFY, Azstarys.
Industry payments across TN — which companies pay providers there.
